Annual ROE
-785.27%
-654.68%-501.32%
31 December 2023
Summary:
Virpax Pharmaceuticals annual return on equity is currently -785.27%, with the most recent change of -654.68% (-501.32%) on 31 December 2023. During the last 3 years, it has fallen by -888.20% (-862.92%). VRPX annual ROE is now -454.65% below its all-time high of 221.42%, reached on 31 December 2018.VRPX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
1283.71%
+2838.45%+182.57%
30 September 2024
Summary:
Virpax Pharmaceuticals quarterly return on equity is currently 1283.71%, with the most recent change of +2838.45% (+182.57%) on 30 September 2024. Over the past year, it has increased by +1391.36% (+1292.48%). VRPX quarterly ROE is now at all-time high.VRPX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRPX ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -501.3% | +1292.5% |
3 y3 years | -862.9% | +2117.5% |
5 y5 years | -454.6% | - |
VRPX ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -862.9% | at low | at high | +182.6% |
5 y | 5 years | -454.6% | at low | at high | +182.6% |
alltime | all time | -454.6% | at low | at high | +182.6% |
Virpax Pharmaceuticals ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 1283.71%(-182.6%) |
June 2024 | - | -1554.74%(+349.5%) |
Mar 2024 | - | -345.90%(+104.6%) |
Dec 2023 | -785.27%(+501.3%) | -169.04%(+57.0%) |
Sept 2023 | - | -107.65%(+12.0%) |
June 2023 | - | -96.12%(+4.1%) |
Mar 2023 | - | -92.33%(+1.8%) |
Dec 2022 | -130.59% | -90.70%(+15.9%) |
Sept 2022 | - | -78.29%(+47.6%) |
June 2022 | - | -53.04%(+6.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -49.78%(-0.9%) |
Dec 2021 | -32.16%(-131.2%) | -50.21%(-21.1%) |
Sept 2021 | - | -63.63%(-79.9%) |
June 2021 | - | -316.07%(-74.0%) |
Mar 2021 | - | -1216.39%(-1229.9%) |
Dec 2020 | 102.93%(-14.9%) | 107.65%(-18.3%) |
Sept 2020 | - | 131.77%(+37.1%) |
June 2020 | - | 96.12%(+93.6%) |
Mar 2020 | - | 49.65%(+93.8%) |
Dec 2019 | 121.02%(-45.3%) | 25.62% |
Dec 2018 | 221.42% | - |
FAQ
- What is Virpax Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual ROE year-on-year change?
- What is Virpax Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly ROE year-on-year change?
What is Virpax Pharmaceuticals annual return on equity?
The current annual ROE of VRPX is -785.27%
What is the all time high annual ROE for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual return on equity is 221.42%
What is Virpax Pharmaceuticals annual ROE year-on-year change?
Over the past year, VRPX annual return on equity has changed by -654.68% (-501.32%)
What is Virpax Pharmaceuticals quarterly return on equity?
The current quarterly ROE of VRPX is 1283.71%
What is the all time high quarterly ROE for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly return on equity is 1283.71%
What is Virpax Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, VRPX quarterly return on equity has changed by +1391.36% (+1292.48%)